Akèy › Maladi selil fòs › New York › New York City
Etid klinik pou Maladi selil fòs nan New York City, NY
13 etid pou Maladi selil fòs ap chèche patisipan nan sit nan ak bò kote New York City (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
A Phase 1b, Open-Label Study of DISC-3405 in Participants With Sickle Cell Disease (SCD)
Ap rekriteFaz 1
- Mount Sinai Hospital, New York
A Research Study Looking at Long-term Treatment With Etavopivat in People With Sickle Cell Disease or Thalassaemia
Ap rekriteFaz 3
- Columbia University Medical Center_New York_0, New York
- Columbia University Medical Center_New York_0, New York
A Phase 2/3 Study of Osivelotor in Adult and Adolescent Participants With SCD
Ap rekriteFaz 2/3
- Icahn School of Medicine at Mount Sinai, New York
ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders
Ap rekriteEtid obsèvasyon
- Weill Cornell Medical College - New York Presbyterian Hospital, New York
Safety, Efficacy, and Pharmacokinetics of CSL889 in Adults and Adolescents With Sickle Cell Disease During Vaso-Occlusive Crisis
Ap rekriteFaz 2
- Mount Sinai Medical Center, New York
Gene Correction in Autologous CD34+ Hematopoietic Stem Cells (HbS to HbA) to Treat Severe Sickle Cell Disease
Ap rekriteFaz 1/2
- Columbia University Irving Medical Center, New York
- Memorial Sloan Kettering, New York
131I-apamistamab-based Conditioning for Hematopoietic Stem Cell Transplant (HSCT) in Advanced Sickle Cell Disease (SCD)
Ap rekriteFaz 1
- Columbia University Irving Medical Center, New York
Comparing the Effectiveness of Matched Related Donor Hematopoietic Stem Cell Transplantation to Disease Modifying Therapy in Pediatric Patients With Sickle Cell Disease
Ap rekriteEtid obsèvasyon
- Columbia Presbytarian (NT-DMT), New York
Evaluation of Efficacy and Safety of a Single Dose of CTX001 in Participants With Transfusion-Dependent β-Thalassemia and Severe Sickle Cell Disease
Ap rekriteFaz 3
- New York Presbyterian Hospital - Morgan Stanley Children's Hospital, New York
Minimizing Toxicity in HLA-identical Sibling Donor Transplantation for Children With Sickle Cell Disease
Ap rekriteFaz 2
- Columbia University, New York
A Long-term Follow-up Study in Patients Who Received BEAM-101
Ap rekriteEtid obsèvasyon
- Columbia University Irving Medical Center, New York
Peer Support for Adolescents and Emerging Adults With Sickle Cell Pain
Ap rekrite
- Weil Cornell Medical College, New York
Cannabinoids for the Reduction of Inflammation and Sickle Cell Related Pain
Ap rekriteFaz 2
- Mount Sinai Hospital, New York
Etid Maladi selil fòs nan lòt vil
- Atlanta, GA22 etid
- Washington, DC20 etid
- Chicago, IL18 etid
- Memphis, TN18 etid
- Philadelphia, PA15 etid
- Birmingham, AL14 etid
- St. Louis, MO12 etid
- Boston, MA10 etid
- Durham, NC10 etid
- Houston, TX10 etid
- Cincinnati, OH10 etid
- Greenville, NC9 etid
Lòt etid nan New York City
- Kansè nan tete136 etid
- Kansè Poumon ki pa ti selil121 etid
- Kansè (tout kalite)109 etid
- Kansè pwostat103 etid
- Kansè Metastatik93 etid
- Kansè kolorektal78 etid
- Kansè ovè69 etid
- Kansè poumon60 etid
- Myelom Miltip60 etid
- Kansè pankreyas60 etid
- Kansè Endomèt52 etid
- Leksemi mieloïd egi51 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.